May 06, 2016

BioTelemetry, Inc. (NASDAQ:BEAT) Appoints Colin Hill to Board of Directors

GNS CEO Colin Hill has been named to the Board of Directors of BioTelemetry, Inc., the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care.

“Mr. Hill’s impressive leadership experience in machine learning in the precision medicine and managed care industries will be instrumental in helping to shape the Company’s strategic direction, especially in the era of big data and personalized medicine,” Joseph Capper, President and Chief Executive Officer of BioTelemetry, Inc., said in an announcement.

Read the complete press release here.